Crossmark

Letter by Neugebauer et al. regarding article “Hypothermia after decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: comment on the randomized clinical trial”

Crossref DOI link: https://doi.org/10.1186/s13054-019-2600-9

Published Online: 2019-09-17

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Neugebauer, Hermann http://orcid.org/0000-0003-3759-356X
Schneider, Hauke

Kollmar, Rainer
License Information

Text and Data Mining valid from 2019-09-17

Version of Record valid from 2019-09-17
More Information

Article History

Received: 29 August 2019

Accepted: 5 September 2019

First Online: 17 September 2019

Ethics approval and consent to participate

: N.A.

: All authors gave consent for publication.

: Dr. Neugebauer reported having financial affiliations with Boehringer Ingelheim, Bayer, and Daiichi-Sankyo.Dr. Kollmar reported having financial affiliations with Boehringer Ingelheim, Bayer, Braincool, and Bard.Dr. Schneider reported no competing interests.

Document is current

Any future updates will be listed below